Loading…
Sertoli-leydig cell tumour of ovary with menorrhagia: a rare case report
Sertoli-Leydig cell tumours (SLCTs) are rare sex cord stromal neoplasms of ovary accounting for less than 0.5% of all ovarian tumours. These are found in women of all age groups (2-75 y), but are most common in reproductive age group with an average age of 25 y. Mostly these are unilateral, confined...
Saved in:
Published in: | Journal of clinical and diagnostic research 2014-10, Vol.8 (10), p.FD18-FD20 |
---|---|
Main Authors: | , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | |
---|---|
cites | |
container_end_page | FD20 |
container_issue | 10 |
container_start_page | FD18 |
container_title | Journal of clinical and diagnostic research |
container_volume | 8 |
creator | Kanade, Umesh Sidheshwar Dantkale, Sunita Sanjay Narkhede, Rahul Ravindra Kurawar, Rupali Ramrao Bansode, Shubhada Yadavrao |
description | Sertoli-Leydig cell tumours (SLCTs) are rare sex cord stromal neoplasms of ovary accounting for less than 0.5% of all ovarian tumours. These are found in women of all age groups (2-75 y), but are most common in reproductive age group with an average age of 25 y. Mostly these are unilateral, confined to ovaries and usually stage I at the time of clinical diagnosis. The common presenting complaints in these patients are due to either mass occupying lesion (mostly pelviabdominal mass and/or pain) or hormonal production (mostly androgen and more rarely oestrogen). Androgenic manifestations, seen in 80% of patients with SLCT, are virilism, hirsutism, receding hairline, breast atrophy, clitoromegaly, acne, hoarseness of voice, etc. Estrogenic manifestations are precocious puberty, abnormal uterine bleeding, abnormal vaginal bleeding, menstrual irregularities, generalised oedema, weight gain, breast hypertrophy, endometrial hyperplasia, endometrial polyps and endometrial carcinoma. Histologically these are classified (WHO) as well-differentiated, intermediately differentiated, poorly differentiated, with heterologous components and retiform type. Prognosis depends upon degree of tumour differentiation (grading) and tumour extent (staging). We herein report an unusual case of SLCT of ovary with oestrogenic manifestation of menorrhagia. |
doi_str_mv | 10.7860/JCDR/2014/9394.5014 |
format | article |
fullrecord | <record><control><sourceid>pubmed_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_9560ec4540224447b0a3106bcdee814e</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_9560ec4540224447b0a3106bcdee814e</doaj_id><sourcerecordid>25478358</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3034-196fcace2043acfc4664d6870093f4fd8618323f8057f79fe329841be840e5313</originalsourceid><addsrcrecordid>eNpVkdtqGzEQhkVJady0TxAIeoGNR9KsDrkIBKdtUgKFHiB3QtaO7A1ry2jXCXn77tZtaK5GjPg__ehj7FTAubEa5l8X19_nEgTOnXJ4Xo-nN2wGzqjKgLs_YjMp0VXGyvtj9r7vHwC01kq_Y8eyRmNVbWfs5geVIXdt1dFz0654pK7jw36T94XnxPNjKM_8qR3WfEPbXMo6rNpwwQMvoRCPoSdeaJfL8IG9TaHr6ePfecJ-ff70c3FT3X37cru4uquiAoWVcDrFEEkCqhBTRK2x0dYAOJUwNVYLq6RKFmqTjEukpLMolmQRqFZCnbDbA7fJ4cHvSrsZG_ocWv9nkcvKhzK0sSPvag0UsUYYPwLRLCEoAXoZGyIrkEbW5YG12y831ETaDiV0r6Cvb7bt2q_yo0c5VjF6BKgDIJbc94XSS1aAnyT5SZKfJPlJkp8kjamz_599yfyzon4DKcaNkg</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Sertoli-leydig cell tumour of ovary with menorrhagia: a rare case report</title><source>PubMed Central Free</source><creator>Kanade, Umesh Sidheshwar ; Dantkale, Sunita Sanjay ; Narkhede, Rahul Ravindra ; Kurawar, Rupali Ramrao ; Bansode, Shubhada Yadavrao</creator><creatorcontrib>Kanade, Umesh Sidheshwar ; Dantkale, Sunita Sanjay ; Narkhede, Rahul Ravindra ; Kurawar, Rupali Ramrao ; Bansode, Shubhada Yadavrao</creatorcontrib><description>Sertoli-Leydig cell tumours (SLCTs) are rare sex cord stromal neoplasms of ovary accounting for less than 0.5% of all ovarian tumours. These are found in women of all age groups (2-75 y), but are most common in reproductive age group with an average age of 25 y. Mostly these are unilateral, confined to ovaries and usually stage I at the time of clinical diagnosis. The common presenting complaints in these patients are due to either mass occupying lesion (mostly pelviabdominal mass and/or pain) or hormonal production (mostly androgen and more rarely oestrogen). Androgenic manifestations, seen in 80% of patients with SLCT, are virilism, hirsutism, receding hairline, breast atrophy, clitoromegaly, acne, hoarseness of voice, etc. Estrogenic manifestations are precocious puberty, abnormal uterine bleeding, abnormal vaginal bleeding, menstrual irregularities, generalised oedema, weight gain, breast hypertrophy, endometrial hyperplasia, endometrial polyps and endometrial carcinoma. Histologically these are classified (WHO) as well-differentiated, intermediately differentiated, poorly differentiated, with heterologous components and retiform type. Prognosis depends upon degree of tumour differentiation (grading) and tumour extent (staging). We herein report an unusual case of SLCT of ovary with oestrogenic manifestation of menorrhagia.</description><identifier>ISSN: 2249-782X</identifier><identifier>EISSN: 0973-709X</identifier><identifier>DOI: 10.7860/JCDR/2014/9394.5014</identifier><identifier>PMID: 25478358</identifier><language>eng</language><publisher>India: JCDR Research and Publications (P) Limited</publisher><subject>menorrhagia ; Pathology Section ; sertoli-leydig cell tumour ; sex cord stromal tumour</subject><ispartof>Journal of clinical and diagnostic research, 2014-10, Vol.8 (10), p.FD18-FD20</ispartof><rights>2014 Journal of Clinical and Diagnostic Research 2014</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4253176/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4253176/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25478358$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kanade, Umesh Sidheshwar</creatorcontrib><creatorcontrib>Dantkale, Sunita Sanjay</creatorcontrib><creatorcontrib>Narkhede, Rahul Ravindra</creatorcontrib><creatorcontrib>Kurawar, Rupali Ramrao</creatorcontrib><creatorcontrib>Bansode, Shubhada Yadavrao</creatorcontrib><title>Sertoli-leydig cell tumour of ovary with menorrhagia: a rare case report</title><title>Journal of clinical and diagnostic research</title><addtitle>J Clin Diagn Res</addtitle><description>Sertoli-Leydig cell tumours (SLCTs) are rare sex cord stromal neoplasms of ovary accounting for less than 0.5% of all ovarian tumours. These are found in women of all age groups (2-75 y), but are most common in reproductive age group with an average age of 25 y. Mostly these are unilateral, confined to ovaries and usually stage I at the time of clinical diagnosis. The common presenting complaints in these patients are due to either mass occupying lesion (mostly pelviabdominal mass and/or pain) or hormonal production (mostly androgen and more rarely oestrogen). Androgenic manifestations, seen in 80% of patients with SLCT, are virilism, hirsutism, receding hairline, breast atrophy, clitoromegaly, acne, hoarseness of voice, etc. Estrogenic manifestations are precocious puberty, abnormal uterine bleeding, abnormal vaginal bleeding, menstrual irregularities, generalised oedema, weight gain, breast hypertrophy, endometrial hyperplasia, endometrial polyps and endometrial carcinoma. Histologically these are classified (WHO) as well-differentiated, intermediately differentiated, poorly differentiated, with heterologous components and retiform type. Prognosis depends upon degree of tumour differentiation (grading) and tumour extent (staging). We herein report an unusual case of SLCT of ovary with oestrogenic manifestation of menorrhagia.</description><subject>menorrhagia</subject><subject>Pathology Section</subject><subject>sertoli-leydig cell tumour</subject><subject>sex cord stromal tumour</subject><issn>2249-782X</issn><issn>0973-709X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNpVkdtqGzEQhkVJady0TxAIeoGNR9KsDrkIBKdtUgKFHiB3QtaO7A1ry2jXCXn77tZtaK5GjPg__ehj7FTAubEa5l8X19_nEgTOnXJ4Xo-nN2wGzqjKgLs_YjMp0VXGyvtj9r7vHwC01kq_Y8eyRmNVbWfs5geVIXdt1dFz0654pK7jw36T94XnxPNjKM_8qR3WfEPbXMo6rNpwwQMvoRCPoSdeaJfL8IG9TaHr6ePfecJ-ff70c3FT3X37cru4uquiAoWVcDrFEEkCqhBTRK2x0dYAOJUwNVYLq6RKFmqTjEukpLMolmQRqFZCnbDbA7fJ4cHvSrsZG_ocWv9nkcvKhzK0sSPvag0UsUYYPwLRLCEoAXoZGyIrkEbW5YG12y831ETaDiV0r6Cvb7bt2q_yo0c5VjF6BKgDIJbc94XSS1aAnyT5SZKfJPlJkp8kjamz_599yfyzon4DKcaNkg</recordid><startdate>20141001</startdate><enddate>20141001</enddate><creator>Kanade, Umesh Sidheshwar</creator><creator>Dantkale, Sunita Sanjay</creator><creator>Narkhede, Rahul Ravindra</creator><creator>Kurawar, Rupali Ramrao</creator><creator>Bansode, Shubhada Yadavrao</creator><general>JCDR Research and Publications (P) Limited</general><general>JCDR Research and Publications Private Limited</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20141001</creationdate><title>Sertoli-leydig cell tumour of ovary with menorrhagia: a rare case report</title><author>Kanade, Umesh Sidheshwar ; Dantkale, Sunita Sanjay ; Narkhede, Rahul Ravindra ; Kurawar, Rupali Ramrao ; Bansode, Shubhada Yadavrao</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3034-196fcace2043acfc4664d6870093f4fd8618323f8057f79fe329841be840e5313</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>menorrhagia</topic><topic>Pathology Section</topic><topic>sertoli-leydig cell tumour</topic><topic>sex cord stromal tumour</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kanade, Umesh Sidheshwar</creatorcontrib><creatorcontrib>Dantkale, Sunita Sanjay</creatorcontrib><creatorcontrib>Narkhede, Rahul Ravindra</creatorcontrib><creatorcontrib>Kurawar, Rupali Ramrao</creatorcontrib><creatorcontrib>Bansode, Shubhada Yadavrao</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>PubMed Central (Full Participant titles)</collection><collection>Directory of Open Access Journals (Open Access)</collection><jtitle>Journal of clinical and diagnostic research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kanade, Umesh Sidheshwar</au><au>Dantkale, Sunita Sanjay</au><au>Narkhede, Rahul Ravindra</au><au>Kurawar, Rupali Ramrao</au><au>Bansode, Shubhada Yadavrao</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Sertoli-leydig cell tumour of ovary with menorrhagia: a rare case report</atitle><jtitle>Journal of clinical and diagnostic research</jtitle><addtitle>J Clin Diagn Res</addtitle><date>2014-10-01</date><risdate>2014</risdate><volume>8</volume><issue>10</issue><spage>FD18</spage><epage>FD20</epage><pages>FD18-FD20</pages><issn>2249-782X</issn><eissn>0973-709X</eissn><abstract>Sertoli-Leydig cell tumours (SLCTs) are rare sex cord stromal neoplasms of ovary accounting for less than 0.5% of all ovarian tumours. These are found in women of all age groups (2-75 y), but are most common in reproductive age group with an average age of 25 y. Mostly these are unilateral, confined to ovaries and usually stage I at the time of clinical diagnosis. The common presenting complaints in these patients are due to either mass occupying lesion (mostly pelviabdominal mass and/or pain) or hormonal production (mostly androgen and more rarely oestrogen). Androgenic manifestations, seen in 80% of patients with SLCT, are virilism, hirsutism, receding hairline, breast atrophy, clitoromegaly, acne, hoarseness of voice, etc. Estrogenic manifestations are precocious puberty, abnormal uterine bleeding, abnormal vaginal bleeding, menstrual irregularities, generalised oedema, weight gain, breast hypertrophy, endometrial hyperplasia, endometrial polyps and endometrial carcinoma. Histologically these are classified (WHO) as well-differentiated, intermediately differentiated, poorly differentiated, with heterologous components and retiform type. Prognosis depends upon degree of tumour differentiation (grading) and tumour extent (staging). We herein report an unusual case of SLCT of ovary with oestrogenic manifestation of menorrhagia.</abstract><cop>India</cop><pub>JCDR Research and Publications (P) Limited</pub><pmid>25478358</pmid><doi>10.7860/JCDR/2014/9394.5014</doi><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 2249-782X |
ispartof | Journal of clinical and diagnostic research, 2014-10, Vol.8 (10), p.FD18-FD20 |
issn | 2249-782X 0973-709X |
language | eng |
recordid | cdi_doaj_primary_oai_doaj_org_article_9560ec4540224447b0a3106bcdee814e |
source | PubMed Central Free |
subjects | menorrhagia Pathology Section sertoli-leydig cell tumour sex cord stromal tumour |
title | Sertoli-leydig cell tumour of ovary with menorrhagia: a rare case report |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T11%3A09%3A46IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Sertoli-leydig%20cell%20tumour%20of%20ovary%20with%20menorrhagia:%20a%20rare%20case%20report&rft.jtitle=Journal%20of%20clinical%20and%20diagnostic%20research&rft.au=Kanade,%20Umesh%20Sidheshwar&rft.date=2014-10-01&rft.volume=8&rft.issue=10&rft.spage=FD18&rft.epage=FD20&rft.pages=FD18-FD20&rft.issn=2249-782X&rft.eissn=0973-709X&rft_id=info:doi/10.7860/JCDR/2014/9394.5014&rft_dat=%3Cpubmed_doaj_%3E25478358%3C/pubmed_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c3034-196fcace2043acfc4664d6870093f4fd8618323f8057f79fe329841be840e5313%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/25478358&rfr_iscdi=true |